Blog
46 Articles
Two Years, Two Diagnoses, Two Chemotherapies, and Two Doctors
Jeanne Jeffries struggled with pain, digestive problems, and itchy skin for two years before getting diagnosed with stage IV pancreatic cancer.
An Update on Drugs for KRAS Mutations
Drugs for KRAS are the focus of a number of clinical trials, and Dr. Allyson Ocean comments on the status of this research.
Fleeting, Fragile, and Funny
Eric Egelman had molecular profiling of his tumor and a KRAS mutation was found. This qualified him for a vaccine clinical trial.
Ready to Fight
Russell Reed lost his father-in-law to pancreatic cancer so he knew how important the right doctor would be for his own treatment.
A Second Opinion Was a Game Changer
Rob Beeler’s treatment for pancreatic cancer took a turn for the better when he went for a second opinion at a major cancer research center.
Determined to Win
After a metastatic pancreatic cancer diagnosis, Linda Chambless sought a second opinion, which led her to a clinical trial.
Too Busy Living Large!
Jane Eshbaugh regularly participated in Roswell Park Cancer Center’s annual fundraising bike ride, not knowing that one day she would be a patient.
A Look Back at Research in 2024
Research in 2024 focused on personally tailored treatments, countering the most difficult effects of pancreatic cancer, and clinical trials.
Genetic Testing and Molecular Profiling Can Guide Treatment
Watch our webinar on Genetic Testing and Molecular Profiling to learn from experts and patients why this is so important.
Genetic Testing Guided My Treatment Plan
Ryan Dwars already knew there was pancreatic cancer in his family so when he was diagnosed he asked for genetic testing right away.
I Feel Very Lucky!
Because of her early career experience as an oncology nurse, Ann Jaffe wanted to participate in a clinical trial.
Let’s Learn About Pancreatic Cancer
Let’s Win and the National Alliance for Hispanic Health’s Nuestras Voces program held their first webinar in Spanish.
Don’t Let Doctors Tell You Nothing’s Wrong
After a long road to diagnosis Brandon Stone learned he has a BRCA2 genetic mutation that impacts his treatment.
Study Reveals Molecular Differences in Young-Onset Pancreatic Cancer
There has been a notable increase in cases of young onset pancreatic cancer. Dr. Jashodeep Datta and team are exploring why this is happening.
I Want to Live!
Every day long-term survivor of pancreatic cancer Doron Bromon sends an important message to the world: I Want to Live!